Thrombocytopenia: An ED Approach

Thrombocytopenia: An ED Approach

By Alex Koyfman MD and Elizabeth Brem MD
(Heme-Onc Fellow, Beth Israel Deaconess Medical Center)
Edited by Stephen Alerhand MD

Etiologies

1) Increased destruction
Immunologic: collagen vascular disease, infection, ITP, lymphoma/CLL, drugs (heparin, sulfonamides, aspirin, phenytoin, digoxin, vancomycin, B-lactam antibiotics)
Mechanical: TTP, HUS, DIC
Vasculitis

2) Decreased production
Decreased megakaryocytes: drugs (EtOH, thiazide, chemo, linezolid), toxins, infection, leukemia
Splenic sequestration

3) Dilutional
– Massive transfusion, ECMO, exchange transfusion

Clinical presentation

– Petechiae, mucosal bleeding (epistaxis, gingival); spontaneous bleeding rare for platelets > 10, post-surgical bleeding rare if platelets > 50
gingival petechiaeback petechiae

 

Suggested work-up:

  • Repeat platelet count – Ensure value is accurate
  • CBC – TTP-HUS presents with anemia AND thrombocytopenia. Abnormal platelets and abnormal WBC count is concerning for primary hematologic etiology.
  • Peripheral smear – Look for schistocytes, and also for platelet clumping to rule out pseudothrombocytopenia. If not comfortable looking at a smear yourself, call Hematology for help. Do not rely on automated instruments to rule in or out the presence of schistocytes.
    thrombocytopenia smear II
  • PT/PTT/INR/fibrinogen – These will be abnormal in DIC and unaffected in other etiologies.
  • Physical exam: look for petechiae, hepatosplenomegaly

 

Whom to admit:

  • Severe thrombocytopenia (i.e. < 20)
  • Platelet count drop > 50% of baseline
  • Suspected leukemia, TTP-HUS, or DIC
  • Active bleeding

 

How to improve:

  • Consider learning how to look at smears. It will be much easier to correctly dispo these patients if you can recognize pseudothrombocytopenia/platelet clumping and schistocytes.
  • Check coags if platelets are low. DIC is a clinical diagnosis, and unlike with MAHA, there are no definitive findings on smear. If suspected, start work-up for underlying infectious cause.

 

Definitions and Learning Points:

HITT
– Heparin-induced thrombocytopenia AND thrombosis
– Use the 4T score: Timing (5-10 days after heparin exposure), degree of Thrombocytopenia (> 50% drop from baseline), no other clear etiology, and Thrombosis
– If intermediate probability, send anti-platelet (PF4) antibody test
– If high probability, start alternative anti-coagulation with argatroban (hepatically-cleared) or bivalirudin (renally-cleared)

ITP
Dx of exclusion
– Acute => child, viral prodrome days-weeks prior, platelets <20, self-limited, supportive care unless active bleeding (steroids, IVIG, anti-Rh Ig)
– Chronic => adult, no prodrome, gradual, platelets 30-100
Life-threatening bleeding: plt transfusions, steroids, IVIG

TTP-HUS
– Usually idiopathic but can be 2/2 meds (clopidogrel, ticlopidine, quinine) or infection (E. coli)
Presume this is the Dx in anyone that presents with thrombocytopenia + microangiopathic hemolytic anemia (pentad of fever, anemia, thrombocytopenia, renal involvement, and neuro involvement [FAT RN] is rare, especially in adults).
– Acute management is with plasmapheresis. If your institution does not have this, start giving FFP and arrange for transfer to a tertiary care center. Do not give platelets, except perhaps in the case of acute hemorrhage (controversial).

Leukemia
– Typically presents with very high white counts, but sometimes can present with leukopenia, especially in the case of acute promyelocytic leukemia (APL). A low white count and DIC is concerning for APL, which is an Oncologic emergency
– Patients should be started on all-trans retinoid acid (ATRA) as soon as the diagnosis is suspected
– When to transfuse platelets: <10 or <50 + active bleeding or <50 + invasive procedure. Of note: transfused platelets last 3-5 days.

 

Further Reading

– Warkentin T. Heparin-Induced Thrombocytopenia: Diagnosis and Management. Circulation 2004;110:e454-e8. http://circ.ahajournals.org/content/110/18/e454.full
http://www.ncbi.nlm.nih.gov/pubmed/25060257
http://www.ncbi.nlm.nih.gov/pubmed/25060255
http://www.ncbi.nlm.nih.gov/pubmed/22445678
http://www.ncbi.nlm.nih.gov/pubmed/17961957

Share This:

1 thought on “Thrombocytopenia: An ED Approach”

  1. Pingback: Thrombocytopenia – EM Clerkship

Leave a Comment

Your email address will not be published. Required fields are marked *

emDOCs subscribes to the Free Open Access Meducation (FOAMed) initiative. Our goal is to inform the global EM community with timely and high-yield content about what providers like YOU are seeing and doing daily in your local ED.

WRITE FOR EMDOCS

We are actively recruiting both new topics and authors.
This project is rolling and you can submit an idea or write-up anytime!
Contact us at editors@emdocs.net

news, headlines, newsletter

Join our Newsletter

Keep up to date on all of the latest new articles, studies, and Podcasts.
Red military tectical backpack bags.